Kramara Juraj Ph.D.

Kramara Juraj Ph.D.'s picture
Phone: +420 585632172
LinkedIn

Publications (Impact Factor Journals):

  • [3]
    PACULOVA, H., J. KRAMARA, S. SIMECKOVA, R. FEDR, K. SOUCEK, O. HYLSE, K. PARUCH, M. SVOBODA, M. MISTRÍK a J. KOHOUTEK. BRCA1 or CDK12 loss sensitizes cells to CHK1 inhibitors. Tumor Biology. 2017, 39(10), 1010428317727479. ISSN 1010-4283. IF: 3.650. PMID: 29025359
  • [2]
    CHROMÁ, K., M. MISTRÍK, P. MOUDRÝ, J. GURSKÝ, M. LIPTAY, R. STRAUSS, Z. ŠKROTT, R. VRTEL, J. BARTKOVA, J. KRAMARA a J. BÁRTEK. Tumors overexpressing RNF168 show altered DNA repair and responses to genotoxic treatments, genomic instability and resistance to proteotoxic stress. Oncogene. 2017, 36(17), 2405-2422. ISSN 0950-9232 . IF: 7.932. PMID: 27841863
  • [1]
    MISTRÍK, M. a J. KRAMARA. DNA damage-related ubiquitinations: one E1 that rules them all. Cell Cycle. 2012, 11(10), 1872-1877. ISSN 1538-4101. IF: 5.321. PMID: 22580454

Doctoral students mentor:

[1] Katarína Chromá, Using novel anti-cancer agents in elucidation of DNA damage response (DDR) mechanisms and their role in onset of cancer,
Ph.D. specialization: , status: Graduated, from: 2012 to 2017


Master students mentor:

[2] Martin Liptay, Post-translational modifications of RNF168 E3 ubiquitin ligase,
status: Graduated, from: 2012 to 2016
[1] Kamila Jahodíková, The role of Aurora-A kinase in the regulation of repair crossink-hedged DNA,
status: Ongoing, from: 2014